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Abstract 
Ionotropic gelation  was used to entrap Ketoprofen in sodium alginate beads. Ketoprofen is NSAIDs category drug; 
it has a short half life (1.5-2 h) and  side effects  such as irritation and ulceration in GIT. Beads were characterized  
for possible sustained drug release .On the basis of differential scanning colorimetry and IR spectroscopy, XRD 
alginate were found to be compatible with Ketoprofen. SEM showed that the beads were spherical and small. 
Ketoprofen encapsulation efficiencies were high (>90%), also results showed that, release profile in 0.1M HCl (pH 
1) was slow. In phosphate buffer complete drug release was shown for all formulations within 6 h. The mechanism 
of release depended on swelling of beads. The swelling behavior dependent on pH of the medium; such a pH 
sensitive swelling could be auspicious for orally administered drug vehicles especially for acid sensitive drugs. 
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Introduction 
 
Gastroretentive drug delivery is an approach to prolong 
gastric residence time, thereby targeting site-specific 
drug release in the upper gastrointestinal tract (GIT) for 
local or systemic effects[1,2]. GRDDS can bost the 
controlled delivery of drugs that have an absorption 
window by  releasing the drug for prolong span of time 
before it passes to its absorption site thus  its maximum 
bioavailability is ensured. Tablets and capsules give an 
immediate release of the drug; but they fail to maintain 
the drug concentration within the therapeutically 
effective range for a required period. To control 
effective plasma drug concentration, these dosage form 
must be administered frequently[3-7]. They also have 
an advantage over the conventional system as it can be 
used to overcome  Floating systems, are low-density 
systems that have proper tendency to float over the 
gastric contents & remain in the stomach for a 
prolonged period. While the system floats over the 
gastric contents, the drug is released slowly at the 
needed rate, which results in increased GRT & lessens 
change in plasma drug concentration[8]. 
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The benefits of floating drug delivery system includes; 
Gastric retention time is increased, site specific drug 
delivery to stomach can be obtained, Drug controlled 
release for a prolonged period & decreased dosing 
frequency, Targeted  local ailments in the upper GIT, 
better therapeutic effect  short half life drugs can be 
obtained, increase absorption and first pass metabolism 
of drugs soluble in stomach & reduced fluctuations of 
drug concentration could be achieved[9-11]. But the 
floating drug delivery system are not feasible for drugs 
having solubility problems in gastric fluid, high level 
of fluids in the stomach is required for maintaining 
float, drugs with powerful first-pass metabolism & 
drugs irritating gastric mucosa are not desirable 
candidates for floating drug delivery system. 
Ketoprofen is rapidly and well-consumed orally, with 
peak plasma levels occurring within 0.5 to 2 hours. No 
active metabolites have been identified. 80% of an 
administered dose of ketoprofen is released in the urine 
after 1day[12,13]. 
Experimental 
Materials  
Ketoprofen (KP) was  provided by Amriya 
Pharmaceuticals & Chem. Ind. Co. (Cairo, Egypt). 
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Sodiumalginate, calcium chloride and gelatin were 
obtained from Chem. and pharma. Co. LTD (England). 
Ethyl cellulose (EC) was procured from Hercules, 
Wilmington, DE. (USA). Hydroxypropyl 
methylcellulose acetate succinate (HPMCAS) was 
procured from Shin Etsu, Tokyo (Japan). Potassium 
dihydrogen orthophosphate, sodium hydroxide, 
hydrochloric acid were purchased from El-Naser 
pharm. And chem. Co. (Egypt), and all other 
ingredients use were of pharmaceutical quality. 
 
Formulation of Sodium Alginate Beads of 
Ketoprofen  
The beads were formulated  by ionotropic gelation. 
Sodium alginate and HPMC E5LV was dissolved in 
water (9:1 sodium alginate: HPMC E5LV) at a conc.  
of 1-3 %w/v using gentle heat over water bath. After 
getting a clear solution, an accurately weighed quantity 
of drug was added and mixed uniformly into the 
solution. The bubble free sodium alginate-drug 
dispersion (20ml) were added drop wise through  22-
guage hypodermic needle fit  with a 10 ml syringe into 
100 ml of calcium chloride solution (1-2%w/v) 
containing 10% glacial acetic acid and stirred at 400 
rpm for 15 min. The droplets from the dispersion 
directly gelled into discrete matrices upon contact with 
the solution of gelling agent. Finally, beads were 
filtered, washed and dried at room temperature[14]. 
Table 1: Composition of Sodium Alginate Beads 
Sr. N. Formulation Code Ketoprofen Sodium 
Alginate 
HPMC CaCl2 
1 F1 100 2% 1% 2% 
2 F2 100 2% 1% 2% 
3 F3 100 2% 1% 2% 
4 F4 100 2% 1% 2% 
5 F5 100 2% 1% 2% 
 
Characterization Studies 
Estimation of Percentage Yield & Drug Entrapment Efficiency: Beads   were crushed and put  in  0.1N HCl. 
After 24 hrs, the solution was filtered and the filtrate was test for drug content[15]. 
                                                                                         Practical drug content 
Drug Entrapment Efficiency =                                                         X 100 
                                                                                          Theoretical drug content 
 
Determination of Swelling Index 
The swelling index was analysed by studying its weight gain. The swelling index of beads was analysed by put the 
beads in the basket of dissolution apparatus using   media 0.1N HCl (pH 1.2) at 37±0.5° at 50 rpm, After 0.5, one, 
two, three, four, and five hours intervals,sample was removed and blotted with tissue paper to remove the excess 
water and weighed on the analytical balance (Shimadzu, AX 120). 
 
Swelling Index =            (Wet weight of beads - Dry weight of beads) 
 
                                                                                                     Dry weight of beads 
Buoyancy Test 
The buoyancy of the beads is done by, soaking 100 
beads in 100ml of 0.1 HCl at pH 1.2. The number of 
floating beads are characterised at fixed time intervals. 
The floating time is measured as the time at which the 
100% of beads floated[16-17]. 
 
 
Morphological Characterization (SEM) 
The samples were coated with a thin gold layer with 
the technique of sputter coater unit Then, SEM 
photographs were taken by a scanning electron 
microscope[18-19]. 
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Fourier Transform Infrared Spectroscopy (FT-IR) 
Studies 
The spectra were recorded on Jasco-5300 FT-IR 
system. Infrared (IR) spectroscopic analysis was 
carried out on the mixtures to know possible 
interactions between the drug and the excepients. 
Samples were prepared by KBr disc technique  and. 
Individual The scanning range was 400–4000 cm-1 and 
the resolution was 1 cm-1. 
Differential Scanning Calorimetry (DSC) Studies 
DSC is a method  to monitor  the structure of a material 
and to obtain information about the physicochemical 
interaction between drug and polymer. In this 
technique, samples (8–10 mg) were weighed  into 
aluminum pans and heated in  nitrogen from 5 to 2500C 
[20-21]. 
X-ray Diffraction (XRD) Studies 
To determine  the crystalline state of the drug in the 
polymer, the X-ray diffraction method of drug loaded 
beads was determined  and compared  with that of pure 
drug.  
In-vitro Drug Release Study 
In-vitro drug release studies were performed  in USP 
type II apparatus at 50 rpm maintained at 37 ± 5°c. A 
sample was transferred into the dissolution medium of 
900 ml of 0.1 N HCl, pH 1.2. Then 5 ml of aliquots 
was withdrawn from the dissolution vessel at specific 
time intervals and changed with equivalent volume of 
fresh medium. Collected dissolution samples were 
filtered using filter paper and then, used for 
determination of released KP concentrations by using a 
UV–Vis spectrophotometer[22]. 
Results and discussion 
Table 2:  Evaluation parameters of different floating alginate beads 
Formulation code % Yield % Entrapment 
Efficiency 
% Floating  Physical Appearance 
Ketoprofen 
  
F1 86.35 36.26 20 Oval 
F2 76.75 38.39 25 Oval 
F3 81.89 91.27 55 Round 
F4 77.97 73.29 30 Round 
F5 78.37 70.29 27 Oval 
 
 
 
F 1 F2 F3 
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Figure 1: Photographs of different sodium alginate beads formulations 
Among of the above formulations, formulation F3 shows good entrapment efficiency but  buoyancy is not good so 
different ratio of calcium carbonate was tried for better buoyancy. 
 
Figure 2: DSC Curve of Ketoprofen + Sodium alginate + Calcium chloride 
 Samples showed relatively deep melting endothermic peak and pure drug show sharp endothermic peak at 97.1 °C  
Ketoprofen respectively. The peak power corresponding to the melting of drugs decreased in the thermo grams of 
mixtures. These results clear  that only a small fraction of the drug was present in the crystalline state.  
 
 
Figure 3: XRD of physical mixture 
F4 F5 
 
Asian Pac. J. Health Sci., 2019; 6(1):199-205                                            e-ISSN: 2349-0659, p-ISSN: 2350-0964 
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Yadav et al                     ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2019;6(1):199-205                                  203 
www.apjhs.com       
 
In-vitro drug release studies 
The in vitro drug release studies of different 
formulations and pure drug were controlled to assure 
the effect of sodium alginate conc. and calcium 
chloride conc. on the release of Ketoprofen from the 
formulations. The in vitro dissolution studies of the 
floating formulations were carried out using USP 
dissolution test apparatus I (basket method). The basket 
of USP dissolution test apparatus I, each containing an 
amount of beads comparable  to 100 mg Ketoprofen 
were rotated at 100 rpm in 900 ml of 0.1N HCl 
maintained at 37°C±0.5 °C. An aliquot of 5 ml of the 
solution was withdrawn at fixed time intervals. 
 
 
Figure 4: In-vitro drug release of different optimized compositions and pure drug in 0.1 N HCl 
The in-vitro dissolution studies of the formulation 
formulation-3 shows maximum percent cumulative 
release with in 12hrs. This shows that Formulation-3  
was having the good sustained release of the 
Ketoprofen up to the 12 hrs. 
Scanning electron microscopy (SEM)  
The morphological characterisationof the optimized 
beads formulation (Formulation-3) was done by 
scanning electron microscopy. SEM study revealed that 
the microspheres almost spherical in shape with rough 
outer surface. 
 
Figure 5: Shape and size of the beads (Formulation-3) 
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Conclusion 
In the present study, a satisfactory attempt has been 
made to formulate gastroretentive floating beads of 
Ketoprofen..  From the experimental study result, it 
was concluded that optimized batch F3 showed good 
micromeritic properties, entrapment efficiency and 
releases drug slowly and completely for 12 hours as 
beads remain in floating condition throughout 
dissolution study that assures prepared formulation 
remain floated in stomach without its early passing to 
lower GIT side. This will help to increase the residence 
time of Ketoprofen in stomach and achieve sustained 
release thereby increase the bioavailability of drugs. 
Finally the prepared floating beads may prove to be 
potential gastroretentive delivery system for safe and 
effective controlled release for an extended period of 
time. 
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